Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

De novo status epilepticus is associated with adverse outcome: An 11-year retrospective study in Hong Kong.

Lui HK, Hui KF, Fong WC, Ip CT, Lui HT.

Seizure. 2016 Aug;40:42-5. doi: 10.1016/j.seizure.2016.06.006. Epub 2016 Jun 14.

2.

Trace metals in surface sediments of the Taiwan Strait: geochemical characteristics and environmental indication.

Gao X, Zhou F, Lui HK, Lou JY, Chen CT, Zhuang W.

Environ Sci Pollut Res Int. 2016 Jun;23(11):10494-503. doi: 10.1007/s11356-015-5669-y. Epub 2015 Oct 30.

PMID:
26514571
3.

Deducing acidification rates based on short-term time series.

Lui HK, Arthur Chen CT.

Sci Rep. 2015 Jul 6;5:11517. doi: 10.1038/srep11517.

4.

Structure-based design, synthesis, and biological evaluation of isatin derivatives as potential glycosyltransferase inhibitors.

Wang Y, Chan FY, Sun N, Lui HK, So PK, Yan SC, Chan KF, Chiou J, Chen S, Abagyan R, Leung YC, Wong KY.

Chem Biol Drug Des. 2014 Dec;84(6):685-96. doi: 10.1111/cbdd.12361. Epub 2014 Aug 14.

PMID:
24890564
5.

Rational design of berberine-based FtsZ inhibitors with broad-spectrum antibacterial activity.

Sun N, Chan FY, Lu YJ, Neves MA, Lui HK, Wang Y, Chow KY, Chan KF, Yan SC, Leung YC, Abagyan R, Chan TH, Wong KY.

PLoS One. 2014 May 13;9(5):e97514. doi: 10.1371/journal.pone.0097514. eCollection 2014.

6.

Vorapaxar in the secondary prevention of atherothrombotic events.

Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA; TRA 2P–TIMI 50 Steering Committee and Investigators.

N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933. Epub 2012 Mar 24.

7.

Clopidogrel with or without omeprazole in coronary artery disease.

Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Scirica BM, Murphy SA, Cannon CP; COGENT Investigators.

N Engl J Med. 2010 Nov 11;363(20):1909-17. doi: 10.1056/NEJMoa1007964. Epub 2010 Oct 6.

8.

Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction.

Stone GW, Martin JL, de Boer MJ, Margheri M, Bramucci E, Blankenship JC, Metzger DC, Gibbons RJ, Lindsay BS, Weiner BH, Lansky AJ, Krucoff MW, Fahy M, Boscardin WJ; AMIHOT-II Trial Investigators.

Circ Cardiovasc Interv. 2009 Oct;2(5):366-75. doi: 10.1161/CIRCINTERVENTIONS.108.840066. Epub 2009 Sep 15.

9.

Practice of breastfeeding and factors that affect breastfeeding in Hong Kong.

Leung EY, Au KY, Cheng SS, Kok SY, Lui HK, Wong WC.

Hong Kong Med J. 2006 Dec;12(6):432-6.

10.

Magnetic resonance imaging for the detection of nasopharyngeal carcinoma.

King AD, Vlantis AC, Tsang RK, Gary TM, Au AK, Chan CY, Kok SY, Kwok WT, Lui HK, Ahuja AT.

AJNR Am J Neuroradiol. 2006 Jun-Jul;27(6):1288-91.

11.

Bailout use of platelet glycoprotein IIb-IIIa inhibition during coronary stent implantation: observations from the ESPRIT trial.

Cantor WJ, Madan M, O'Shea JC, Chisholm RJ, Lui HK, Cohen DJ, Feldman RL, Green R, Hellkamp AS, Kitt MM, Tcheng JE.

J Invasive Cardiol. 2005 Jul;17(7):360-4.

PMID:
16003020
12.

Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease.

Lansky AJ, Costa RA, Mooney M, Midei MG, Lui HK, Strickland W, Mehran R, Leon MB, Russell ME, Ellis SG, Stone GW; TAXUS-IV Investigators.

J Am Coll Cardiol. 2005 Apr 19;45(8):1180-5.

13.

Comparative pharmacodynamic evaluation of eptifibatide and abciximab in patients with non-ST-segment elevation acute coronary syndromes: the TAM2 study.

Saucedo JF, Lui HK, Garza L, Guerra GJ, Jacoski MV, Jennings LK.

J Thromb Thrombolysis. 2004 Oct;18(2):67-74. Erratum in: J Thromb Thrombolysis. 2005 Apr;19(2):139. Dosage error in published abstract; MEDLINE/PubMed abstract corrected.

PMID:
15789173
14.

Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy.

Gibson CM, Murphy SA, Marble SJ, Cohen DJ, Cohen EA, Lui HK, Young J Jr, Kitt MM, Lorenz TJ, Tcheng JE.

Am Heart J. 2002 Jan;143(1):106-10.

PMID:
11773919
15.

Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial.

Blankenship JC, Tasissa G, O'Shea JC, Iliadis EA, Bachour FA, Cohen DJ, Lui HK, Mann T 3rd, Cohen E, Tcheng JE; ESPRIT Investigators.

J Am Coll Cardiol. 2001 Sep;38(3):653-8.

16.

Mitral valve replacement and endocavitary patch repair for a giant left ventricular pseudoaneurysm.

Kollar A, Byrd BF 3rd, Lui HK, Drinkwater DC Jr.

Ann Thorac Surg. 2001 Jun;71(6):2020-2.

PMID:
11426790
17.

Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy.

Gibson CM, Cohen DJ, Cohen EA, Lui HK, Murphy SA, Marble SJ, Kitt M, Lorenz T, Tcheng JE.

Am J Cardiol. 2001 Jun 1;87(11):1293-5. No abstract available.

PMID:
11377359
18.

Dosage, pharmacological effects and clinical outcomes for bivalirudin in percutaneous coronary intervention.

Lui HK.

J Invasive Cardiol. 2000 Dec;12 Suppl F:41F-52. Review. No abstract available.

PMID:
11156734
19.

Comparison of intravenous mexiletine and lidocaine for the treatment of ventricular arrhythmias.

Lui HK, Harris FJ, Chan MC, Lee G, Mason DT.

Am Heart J. 1986 Dec;112(6):1153-8.

PMID:
3788761
20.

Reduction of ventricular ectopic beats with oral acebutolol: a double-blind, randomized crossover study.

Lui HK, Lee G, Dhurandhar R, Hungate EJ, Laddu A, Dietrich P, Mason DT.

Am Heart J. 1983 May;105(5):722-6.

PMID:
6846115

Supplemental Content

Loading ...
Support Center